Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR Study.
Thiery-Vuillemin A, Theodore C, Jacobasch L, Schmitz J, Papandreou C, Guillot A, Emmanouilides C, Slimane K, Kelkouli N, Kim S, Nguyen Tan Hon T. Thiery-Vuillemin A, et al. Among authors: guillot a. Clin Genitourin Cancer. 2015 Jun;13(3):231-8. doi: 10.1016/j.clgc.2014.09.005. Epub 2014 Nov 20. Clin Genitourin Cancer. 2015. PMID: 25456838
General management of nonagenarian patients: a review of the literature.
Rivoirard R, Chargari C, Trone JC, Falk AT, Guy JB, Eddekaoui H, Lahmar R, Pacaut C, Mery B, Assouline A, Auberdiac P, Moriceau G, Gonthier R, Guillot A, Merrouche Y, Magné N. Rivoirard R, et al. Among authors: guillot a. Swiss Med Wkly. 2014 Dec 23;144:w14059. doi: 10.4414/smw.2014.14059. eCollection 2014. Swiss Med Wkly. 2014. PMID: 25536522 Free article. Review.
Hypofractionated radiation therapy for treatment of bladder carcinoma in patients aged 90 years and more: A new paradigm to be explored?
Méry B, Falk AT, Assouline A, Trone JC, Guy JB, Rivoirard R, Auberdiac P, Escure JL, Moncharmont C, Moriceau G, Almokhles H, de Laroche G, Pacaut C, Guillot A, Chargari C, Magné N. Méry B, et al. Among authors: guillot a. Int Urol Nephrol. 2015 Jul;47(7):1129-34. doi: 10.1007/s11255-015-0999-8. Epub 2015 May 17. Int Urol Nephrol. 2015. PMID: 25982585
Safety assessment of molecular targeted therapies in association with radiotherapy in metastatic renal cell carcinoma: a real-life report.
Langrand-Escure J, Vallard A, Rivoirard R, Méry B, Guy JB, Espenel S, Trone JC, Ben Mrad M, Diao P, Rancoule C, Suchaud JP, Fournel P, Guillot A, Chargari C, Escudier B, Négrier S, Magné N. Langrand-Escure J, et al. Among authors: guillot a. Anticancer Drugs. 2016 Jun;27(5):427-32. doi: 10.1097/CAD.0000000000000349. Anticancer Drugs. 2016. PMID: 27045782
Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma-Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study.
Oudard S, Geoffrois L, Guillot A, Chevreau C, Deville JL, Falkowski S, Boyle H, Baciuchka M, Gimel P, Laguerre B, Laramas M, Pfister C, Topart D, Rolland F, Legouffe E, Denechere G, Amela EY, Abadie-Lacourtoisie S, Gross-Goupil M. Oudard S, et al. Among authors: guillot a. Eur J Cancer. 2016 Jul;62:28-35. doi: 10.1016/j.ejca.2016.04.003. Epub 2016 May 15. Eur J Cancer. 2016. PMID: 27192659
371 results